Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
Can IL-33 Pathway Revolutionize Immunotherapy in Pancreatic Cancer?
Research & Development Can IL-33 Pathway Revolutionize Immunotherapy in Pancreatic Cancer?

Recent advancements in cancer research have brought to light exciting new possibilities in the realm of immunotherapy, particularly concerning pancreatic cancer. Led by Dr. Vinod Balachandran, a team at Memorial Sloan Kettering Cancer Center (MSK) has made groundbreaking discoveries related to the

January 16, 2025
Advancements in Genetic Testing Bring New Hope for Affected Families
Research & Development Advancements in Genetic Testing Bring New Hope for Affected Families

Recent advancements in genetic testing have brought significant hope to families facing challenges related to fertility issues and genetic disorders. The Pioneers in Genetic Testing Innovative techniques in pre-implantation genetic testing (PGT) and non-invasive prenatal testing (NIPT) are

January 16, 2025
Can AI Identify Cognitive Decline in Menopausal Women Effectively?
Tech & Innovation Can AI Identify Cognitive Decline in Menopausal Women Effectively?

Artificial Intelligence has seen numerous applications in healthcare, yet one of the most promising areas is its ability to identify cognitive decline in menopausal women. Recent studies have indicated that machine learning can play a crucial role in recognizing women at risk of severe subjective

January 15, 2025
Can In-House NGS Revolutionize Personalized Cancer Treatment in Malaysia?
Research & Development Can In-House NGS Revolutionize Personalized Cancer Treatment in Malaysia?

The transformative impact of rapid in-house next-generation sequencing (NGS) technology on cancer treatment is becoming increasingly evident. This advancement is particularly significant in enabling personalized medicine and improving patient outcomes. With the progress in molecular testing and the

January 15, 2025
How Will UQ and Vaxxas' Patch Revolutionize COVID-19 mRNA Vaccines?
Research & Development How Will UQ and Vaxxas' Patch Revolutionize COVID-19 mRNA Vaccines?

Imagine a world where getting vaccinated no longer means facing a needle and syringe, but instead, involves a simple patch applied to the skin. This prospect is rapidly becoming a reality thanks to the innovative work of the University of Queensland (UQ) and Brisbane-based biotech company Vaxxas.

January 14, 2025
How Did Digital Health Venture Funding Change in 2024?
Tech & Innovation How Did Digital Health Venture Funding Change in 2024?

Digital health venture funding in 2024 experienced notable shifts and trends that shaped the investment landscape. This article delves into the dynamics of venture capital investments, the trends in deal sizes and stages of funding, the influence of major investors, and the sectors within digital

January 14, 2025
Genetic Discovery Could Revolutionize Pan-Cancer Metastasis Treatments
Research & Development Genetic Discovery Could Revolutionize Pan-Cancer Metastasis Treatments

A groundbreaking discovery in cancer research has unveiled a "genetic signature" involving 177 genes that are shared across multiple cancer types, fundamentally challenging prior assumptions about the mechanisms driving cancer metastasis. These findings open new avenues for innovative

January 10, 2025
MUVON's Muscle Regeneration Therapy Offers Hope for Women's Health
Biotech & Bioprocessing MUVON's Muscle Regeneration Therapy Offers Hope for Women's Health

The advancements in muscle regeneration technology by Swiss biotech company MUVON Therapeutics are making waves, especially in the realm of treating stress urinary incontinence in women. This breakthrough holds the potential to improve the quality of life for millions while extending healthspan.

January 10, 2025
Turkish Health Workers Protest Against Profit-Driven Regulations
Management & Regulatory Turkish Health Workers Protest Against Profit-Driven Regulations

Amid growing discontent with the Turkish healthcare system, a coalition of health workers has taken decisive action to protest against new regulations they argue prioritize profit over patient care. Beginning with a five-day work stoppage on January 6, these protests culminated in a general

January 10, 2025
Stanford Unveils AI Model MUSK Enhancing Cancer Prognosis and Treatment
Research & Development Stanford Unveils AI Model MUSK Enhancing Cancer Prognosis and Treatment

Stanford Medicine researchers have recently introduced an innovative artificial intelligence (AI) model named MUSK (multimodal transformer with unified mask modeling) that significantly improves the accuracy of cancer prognosis predictions. By integrating both visual and textual medical data, this

January 9, 2025
Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later